Posaconazole: new antifungal agent promising in seriously ill patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1412, 2003-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Posaconazole prophylaxis proves promising

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme

By Rayner C.R.  

Clinical Pharmacokinetics, Vol. 42, Iss. 15, 2003-01 ,pp. : 1411-1423

Adis International

Access to resources Recommend Favorite

Posaconazole most worthy antifungal in AML

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

BOND: Cetuximab a promising new agent for colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Milatuzumab: a promising new agent for the treatment of lymphoid malignancies

By Mark Tomer   Martin Peter   Leonard John P   Niesvizky Ruben  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite